0001209191-16-092226.txt : 20160119
0001209191-16-092226.hdr.sgml : 20160118
20160119190034
ACCESSION NUMBER: 0001209191-16-092226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160115
FILED AS OF DATE: 20160119
DATE AS OF CHANGE: 20160119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProNAi Therapeutics Inc
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glover Nicholas
CENTRAL INDEX KEY: 0001578888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 161349400
MAIL ADDRESS:
STREET 1: C/O PRONAI THERAPEUTICS, INC.
STREET 2: 2150 - 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-15
0
0001290149
ProNAi Therapeutics Inc
DNAI
0001578888
Glover Nicholas
C/O PRONAI THERAPEUTICS, INC.
2150 885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
1
1
0
0
CEO and President
Common Stock
2016-01-15
4
M
0
5000
0.969
A
5000
D
Common Stock
2016-01-15
4
S
0
5000
10.0446
D
0
D
Stock Option (right to buy)
0.969
2016-01-15
4
M
0
5000
0.00
D
2024-07-13
Common Stock
5000
864219
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.29 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests as to 25% of the total shares on July 14, 2015, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on July 14, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. The option is immediately exercisable.
/s/ Sukhi Jagpal as attorney-in-fact for Nick Glover, Ph.D.
2016-01-19